These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 18772112)

  • 21. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
    Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer and genetic alterations in the Wnt pathway.
    Segditsas S; Tomlinson I
    Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
    Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
    Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.
    Martinez G; Wijesinghe M; Turner K; Abud HE; Taketo MM; Noda T; Robinson ML; de Iongh RU
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4794-806. PubMed ID: 19515997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumorigenesis: TCF4 feeds c-Jun.
    Raftopoulou M
    Nat Cell Biol; 2005 Oct; 7(10):932. PubMed ID: 16195746
    [No Abstract]   [Full Text] [Related]  

  • 26. Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1-/- mice.
    Leung N; Turbide C; Balachandra B; Marcus V; Beauchemin N
    Oncogene; 2008 Aug; 27(36):4943-53. PubMed ID: 18454175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
    J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the glutathione peroxidase 2 (GPx2) promoter by beta-catenin.
    Kipp A; Banning A; Brigelius-Flohé R
    Biol Chem; 2007 Oct; 388(10):1027-33. PubMed ID: 17937616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
    Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
    Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
    BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.
    Cortina C; Palomo-Ponce S; Iglesias M; Fernández-Masip JL; Vivancos A; Whissell G; Humà M; Peiró N; Gallego L; Jonkheer S; Davy A; Lloreta J; Sancho E; Batlle E
    Nat Genet; 2007 Nov; 39(11):1376-83. PubMed ID: 17906625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.
    Yan S; Zhou C; Zhang W; Zhang G; Zhao X; Yang S; Wang Y; Lu N; Zhu H; Xu N
    Cancer Lett; 2008 Nov; 271(1):85-97. PubMed ID: 18602747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Intestinal Wnt/TCF Signature.
    Van der Flier LG; Sabates-Bellver J; Oving I; Haegebarth A; De Palo M; Anti M; Van Gijn ME; Suijkerbuijk S; Van de Wetering M; Marra G; Clevers H
    Gastroenterology; 2007 Feb; 132(2):628-32. PubMed ID: 17320548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling.
    Hsieh A; Kim HS; Lim SO; Yu DY; Jung G
    Cancer Lett; 2011 Jan; 300(2):162-72. PubMed ID: 20971552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression.
    Chen XY; Wang ZC; Li H; Cheng XX; Sun Y; Wang XW; Wu ML; Liu J
    Hum Pathol; 2005 Dec; 36(12):1294-301. PubMed ID: 16311123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eukaryotic initiation factor 6 selectively regulates Wnt signaling and beta-catenin protein synthesis.
    Ji Y; Shah S; Soanes K; Islam MN; Hoxter B; Biffo S; Heslip T; Byers S
    Oncogene; 2008 Jan; 27(6):755-62. PubMed ID: 17667944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further upregulation of beta-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of ApcMin/+ mice.
    Oyama T; Yamada Y; Hata K; Tomita H; Hirata A; Sheng H; Hara A; Aoki H; Kunisada T; Yamashita S; Mori H
    Carcinogenesis; 2008 Mar; 29(3):666-72. PubMed ID: 18204079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells.
    Lin FC; Liu YP; Lai CH; Shan YS; Cheng HC; Hsu PI; Lee CH; Lee YC; Wang HY; Wang CH; Cheng JQ; Hsiao M; Lu PJ
    Oncogene; 2012 Sep; 31(39):4302-16. PubMed ID: 22231444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.